4//SEC Filing
Branning Todd P. 4
Accession 0001104659-23-033858
CIK 0001173281other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:11 PM ET
Size
5.4 KB
Accession
0001104659-23-033858
Insider Transaction Report
Form 4
Branning Todd P.
Chief Financial Officer
Transactions
- Award
Common stock
2023-03-16+54,200→ 84,200 total
Footnotes (1)
- [F1]Restricted stock units to be settled by the issuance of one share of common stock for each restricted stock unit that is earned; 25% of which shall vest on March 16, 2024 and the remainder of which shall vest monthly thereafter until March 16, 2027, provided that vesting shall only occur on a scheduled vesting date if employment has not terminated prior to such vesting date, inclusive. Restricted stock units are subject to accelerated vesting, subject to certain conditions, in the event of a change of control of the Issuer.
Documents
Issuer
NeuBase Therapeutics, Inc.
CIK 0001173281
Entity typeother
Related Parties
1- filerCIK 0001765274
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 4:11 PM ET
- Size
- 5.4 KB